The impact of somatic and cognitive depressive symptoms on medical prognosis in patients with end-stage renal disease

Abstract

Purpose:

To determine whether somatic or cognitive depressive symptoms affect hospitalization and death in patients with end-stage renal disease.

Design and Method:

In an observational retrospective design, the patients (n = 190) completed the Beck Depression Inventory-II at baseline and were followed for 5 years to collect data all-cause mortality and hospitalization.

Findings:

High somatic (53.7%, n = 102) and cognitive (52.1%, n = 99) depressive symptoms scores significantly associated with mortality (38% vs. 19%; hazard ratio [HR] = 2; 95% CI, 1.1–3.7; p = 0.02) and hospitalization (62.5% vs. 49.4%; HR = 1.6; 95% CI, 1.0–2.6; p = 0.03), respectively.

Practice Implications:

In the context of diagnosing and intervening, awareness of depressive symptoms dimensionality is crucial.

RAS ID

35625

Document Type

Journal Article

Date of Publication

1-1-2022

Volume

58

Issue

1

Funding Information

The Deanship of Scientific Research - The University of Jordan

PubMed ID

33861469

School

School of Nursing and Midwifery

Copyright

subscription content

Publisher

Wiley

Comments

Khalil, A. A., Darawad, M. W., Abed, M. A., Hamdan‐Mansour, A., Arabiat, D. H., Alnajar, M. K., & Saleh, Z. T. (2022). The impact of somatic and cognitive depressive symptoms on medical prognosis in patients with end‐stage renal disease. Perspectives in Psychiatric Care, 58(1), 297-303.

https://doi.org/10.1111/ppc.12786

Share

 
COinS
 

Link to publisher version (DOI)

10.1111/ppc.12786